4522 Federal Register / Vol. 72, No. 20 / Wednesday, January 31, 2007 / Notices 

Dated: January 23, 2007. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–401 Filed 1–30–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Initial Review Group; Subcommittee 

1—Career Development. 

Date: February 27–28, 2007. 

Time: 8 a.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Hilton Alexandria Old Town, 

1767 King Street, Alexandria, VA 22314. 

Contact Person: Robert Bird, PhD, 

Scientific Review Administrator, Resources 

and Training Review Branch, National 

Cancer Institute, National Institutes of 

Health, 6116 Executive Blvd., Room 8113, 

MSC 8328, Bethesda, MD 20892–8328, 301–

496–7978, birdr@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Innovative 

Technologies for Molecular Analysis of 

Cancer. 

Date: March 7–8, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott, 5151 Pooks Hill 

Road, Bethesda, MD 20814. 

Contact Person: Sherwood Githens, PhD, 

Scientific Review Administrator, Special 

Review and Logistics Branch, National 

Cancer Institute, Division of Extramural 

Activities, 6116 Executive Blvd., Room 8053, 

Bethesda, MD 20892, 301–435–1822, 

githenss@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, TW06–006 

‘‘International Tobacco and Health Research 

and Building Capacity.’’

Date: March 20–21, 2007. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Courtyard Gaithersburg 

Washingtonian Center, 204 Boardwalk Place, 

Gaithersburg, MD 20878. 

Contact Person: Gerald G. Lovinger, PhD, 

Scientific Review Administrator, Special 

Review and Logistics Branch, Division of 

Extramural Activities, National Cancer 

Institute, 6116 Executive Blvd., Room 8101, 

Bethesda, MD 20892–8329, 301–496–7987, 

lovingeg@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: January 23, 2007. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–402 Filed 1–30–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Amended Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the National Heart, Lung, 

and Blood Institute Special Emphasis 

Panel, February 23, 2007, 8:30 a.m. to 

February 23, 2007, 3 p.m., Embassy 

Suites Hotel Washington Convention 

Ctr., Washington, DC 20001 which was 

published in the Federal Register on 

January 12, 2007, FR 07–100. 

The February 23, 2007 Meeting Panel 

Name was changed from Modified 

Hemoglobin Production to VAD 

Technologies. The meeting is closed to 

the public. 

Dated: January 24, 2007. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–397 Filed 1–30–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Amended Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the National Heart, Lung, 

and Blood Institute Special Emphasis 

Panel, February 20, 2007, 2 p.m. to 

February 20, 2007, 3 p.m., National 

Institutes of Health, 6701 Rockledge 

Drive, Bethesda, MD 20892 which was 

published in the Federal Register on 

January 12, 2007, FR 07–100. 

The February 20, 2007 Meeting Panel 

Name was changed from VAD 

Technologies to Modified Hemoglobin 

Production. The meeting is closed to the 

public. 

Dated: January 24, 2007. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–398 Filed 1–30–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Dental & 

Craniofacial Research; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Dental and Craniofacial Research Special 

Emphasis Panel; 07–43, Review R03, F30. 

Date: February 12, 2007. 

Time: 1:30 p.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Bethesda, 

MD 20892, (Telephone Conference Call). 

Contact Person: Raj K. Krishnaraju, PhD, 

MS, Scientific Review Administrator, 

Scientific Review Branch, National Inst. of 

Dental & Craniofacial Research, National 

Institutes of Health, 45 Center Dr. Rm 4AN 

32J, Bethesda, MD 20892, 301–594–4864, 

kkrishna@nidcr.nih.gov. 

Name of Committee: National Institute of 

Dental and Craniofacial Research Special 

Emphasis Panel; 07–35, Review R21. 

Date: March 1, 2007. 

Time: 11 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

mstockstill on PROD1PC62 with NOTICES